{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T18:23:43Z","timestamp":1793298223225,"version":"4.5.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lungcancerjournal.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.lungcan.2020.05.019","type":"journal-article","created":{"date-parts":[[2020,5,24]],"date-time":"2020-05-24T01:38:08Z","timestamp":1590284288000},"page":"154-159","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["NTRK and ALK rearrangements in malignant pleural mesothelioma, pulmonary neuroendocrine tumours and non-small cell lung cancer"],"prefix":"10.1016","volume":"146","author":[{"given":"Jose Luis","family":"Leal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"Szaumkessel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trishe","family":"Leong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khashayar","family":"Asadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gareth","family":"Rivalland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongdo","family":"Do","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare","family":"Senko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul L.","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chai Zi","family":"Quing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Dobrovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bibhusal","family":"Thapa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"John","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.lungcan.2020.05.019_bib0005","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/PAI.0000000000000360","article-title":"Detecting gene rearrangements in patient populations through a 2-step diagnostic test comprised of rapid IHC enrichment followed by sensitive next-generation sequencing","volume":"25","author":"Murphy","year":"2017","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"issue":"1","key":"10.1016\/j.lungcan.2020.05.019_bib0010","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/s41379-018-0118-3","article-title":"Molecular characterization of cancers with NTRK gene fusions","volume":"32","author":"Gatalica","year":"2019","journal-title":"Mod. Pathol."},{"issue":"13","key":"10.1016\/j.lungcan.2020.05.019_bib0015","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1158\/0008-5472.CAN-19-0372","article-title":"Detection of NTRK fusions: merits and limitations of current diagnostic platforms","volume":"79","author":"Solomon","year":"2019","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.lungcan.2020.05.019_bib0020","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/ng0298-184","article-title":"A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma","volume":"18","author":"Knezevich","year":"1998","journal-title":"Nat. Genet."},{"issue":"12","key":"10.1016\/j.lungcan.2020.05.019_bib0025","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.5858\/arpa.2010-0351-RS","article-title":"Secretory breast carcinoma: unique, triple-negative carcinoma with a favorable prognosis and characteristic molecular expression","volume":"135","author":"Vasudev","year":"2011","journal-title":"Arch. Pathol. Lab. Med."},{"issue":"5","key":"10.1016\/j.lungcan.2020.05.019_bib0030","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/PAS.0b013e3181d9efcc","article-title":"Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity","volume":"34","author":"Sk\u00e1lov\u00e1","year":"2010","journal-title":"Am. J. Surg. Pathol."},{"issue":"8","key":"10.1016\/j.lungcan.2020.05.019_bib0035","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1056\/NEJMoa1714448","article-title":"Efficacy of Larotrectinib in TRK fusion-positive cancers in adults and children","volume":"378","author":"Drilon","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.lungcan.2020.05.019_bib0040","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1177\/1093526617712639","article-title":"Infantile NTRK-associated mesenchymal tumors","volume":"21","author":"Davis","year":"2018","journal-title":"Pediatr. Dev. Pathol."},{"issue":"10","key":"10.1016\/j.lungcan.2020.05.019_bib0045","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1158\/2159-8290.CD-15-0443","article-title":"An oncogenic NTRK fusion in a patient with soft-tissue sarcoma with response to the tropomyosin-related kinase inhibitor LOXO-101","volume":"5","author":"Doebele","year":"2015","journal-title":"Cancer Discov."},{"key":"10.1016\/j.lungcan.2020.05.019_bib0050","doi-asserted-by":"crossref","first-page":"557","DOI":"10.3389\/fonc.2018.00557","article-title":"ALK inhibitors in the treatment of ALK positive NSCLC","volume":"8","author":"Khan","year":"2018","journal-title":"Front. Oncol."},{"issue":"11","key":"10.1016\/j.lungcan.2020.05.019_bib0055","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/j.jtho.2017.08.002","article-title":"Recent advances in targeting ROS1 in lung Cancer","volume":"12","author":"Lin","year":"2017","journal-title":"J. Thorac. Oncol."},{"issue":"10","key":"10.1016\/j.lungcan.2020.05.019_bib0060","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1158\/2159-8290.CD-18-0484","article-title":"Repotrectinib (TPX-0005) is a next-generation ROS1\/TRK\/ALK inhibitor that potently inhibits ROS1\/TRK\/ALK solvent-front mutations","volume":"8","author":"Drilon","year":"2018","journal-title":"Cancer Discov."},{"issue":"4","key":"10.1016\/j.lungcan.2020.05.019_bib0065","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1158\/2159-8290.CD-16-1237","article-title":"Safety and antitumor activity of the multitargeted Pan-TRK, ROS1, and ALK inhibitor entrectinib: combined results from two phase I trials (ALKA-372-001 and STARTRK-1)","volume":"7","author":"Drilon","year":"2017","journal-title":"Cancer Discov."},{"issue":"10","key":"10.1016\/j.lungcan.2020.05.019_bib0070","doi-asserted-by":"crossref","first-page":"S321","DOI":"10.1016\/j.jtho.2018.08.239","article-title":"OA02.01 efficacy and safety of entrectinib in locally advanced or metastatic ROS1 fusion-positive non-small cell lung Cancer (NSCLC)","volume":"13","author":"Doebele","year":"2018","journal-title":"J. Thorac. Oncol."},{"issue":"9","key":"10.1016\/j.lungcan.2020.05.019_bib0075","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1097\/JTO.0000000000000663","article-title":"Introduction to the 2015 world health organization classification of tumors of the lung, Pleura, Thymus, and heart","volume":"10","author":"Travis","year":"2015","journal-title":"J. Thorac. Oncol."},{"issue":"4","key":"10.1016\/j.lungcan.2020.05.019_bib0080","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/ng.3520","article-title":"Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations","volume":"48","author":"Bueno","year":"2016","journal-title":"Nat. Genet."},{"issue":"2","key":"10.1016\/j.lungcan.2020.05.019_bib0085","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1158\/0008-5472.CAN-14-1008","article-title":"Whole-exome sequencing reveals frequent genetic alterations in BAP1, NF2, CDKN2A, and CUL1 in malignant pleural mesothelioma","volume":"75","author":"Guo","year":"2015","journal-title":"Cancer Res."},{"issue":"12","key":"10.1016\/j.lungcan.2020.05.019_bib0090","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1158\/2159-8290.CD-18-0804","article-title":"Integrative molecular characterization of malignant pleural mesothelioma","volume":"8","author":"Hmeljak","year":"2018","journal-title":"Cancer Discov."},{"issue":"4","key":"10.1016\/j.lungcan.2020.05.019_bib0095","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/S0002-9440(10)65653-2","article-title":"Typical and atypical carcinoid tumors of the lung are characterized by 11q deletions as detected by comparative genomic hybridization","volume":"153","author":"Walch","year":"1998","journal-title":"Am. J. Pathol."},{"issue":"7","key":"10.1016\/j.lungcan.2020.05.019_bib0100","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1158\/1078-0432.CCR-17-0252","article-title":"Pathways impacted by genomic alterations in pulmonary carcinoid tumors","volume":"24","author":"Asiedu","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.lungcan.2020.05.019_bib0105","doi-asserted-by":"crossref","first-page":"4991","DOI":"10.2147\/OTT.S172124","article-title":"ALK-rearrangement neuroendocrine carcinoma of the lung: a comprehensive study of a rare case series and review of literature","volume":"11","author":"Zheng","year":"2018","journal-title":"Onco. Ther."},{"issue":"7","key":"10.1016\/j.lungcan.2020.05.019_bib0110","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1634\/theoncologist.2017-0054","article-title":"A case of metastatic atypical neuroendocrine tumor with ALK translocation and diffuse brain metastases","volume":"22","author":"Wang","year":"2017","journal-title":"Oncologist"},{"issue":"4","key":"10.1016\/j.lungcan.2020.05.019_bib0115","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jtho.2016.01.012","article-title":"Small cell lung cancer: Can recent advances in biology and molecular biology Be translated into improved outcomes?","volume":"11","author":"Bunn","year":"2016","journal-title":"J. Thorac. Oncol."},{"issue":"5","key":"10.1016\/j.lungcan.2020.05.019_bib0120","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41568-019-0133-9","article-title":"Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data","volume":"19","author":"Rudin","year":"2019","journal-title":"Nat. Rev. Cancer"},{"issue":"9411","key":"10.1016\/j.lungcan.2020.05.019_bib0125","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S0140-6736(04)15693-6","article-title":"Two prognostically significant subtypes of high-grade lung neuroendocrine tumours independent of small-cell and large-cell neuroendocrine carcinomas identified by gene expression profiles","volume":"363","author":"Jones","year":"2004","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.lungcan.2020.05.019_bib0130","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/j.1349-7006.2005.00092.x","article-title":"Array-based comparative genomic hybridization analysis of high-grade neuroendocrine tumors of the lung","volume":"96","author":"Peng","year":"2005","journal-title":"Cancer Sci."},{"issue":"9","key":"10.1016\/j.lungcan.2020.05.019_bib0135","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1158\/2159-8290.CD-12-0112","article-title":"Proteomic profiling identifies dysregulated pathways in small cell lung cancer and novel therapeutic targets including PARP1","volume":"2","author":"Byers","year":"2012","journal-title":"Cancer Discov."},{"issue":"14","key":"10.1016\/j.lungcan.2020.05.019_bib0140","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1158\/1078-0432.CCR-15-2946","article-title":"Next-generation sequencing of pulmonary large cell neuroendocrine carcinoma reveals small cell carcinoma-like and non-small cell carcinoma-like subsets","volume":"22","author":"Rekhtman","year":"2016","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.lungcan.2020.05.019_bib0145","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1038\/s41467-018-03099-x","article-title":"Integrative genomic profiling of large-cell neuroendocrine carcinomas reveals distinct subtypes of high-grade neuroendocrine lung tumors","volume":"9","author":"George","year":"2018","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.lungcan.2020.05.019_bib0150","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.lungcan.2013.05.022","article-title":"An extremely rare case of small-cell lung cancer harboring variant 2 of the EML4-ALK fusion gene","volume":"81","author":"Toyokawa","year":"2013","journal-title":"Lung Cancer"},{"issue":"2","key":"10.1016\/j.lungcan.2020.05.019_bib0155","doi-asserted-by":"crossref","first-page":"167","DOI":"10.21037\/tlcr.2019.03.11","article-title":"Mesenchyme to epithelial transition protein expression, gene copy number and clinical outcome in a large non-small cell lung cancer surgical cohort","volume":"8","author":"Rivalland","year":"2019","journal-title":"Transl. Lung Cancer Res."},{"key":"10.1016\/j.lungcan.2020.05.019_bib0160","doi-asserted-by":"crossref","first-page":"vii11","DOI":"10.1093\/annonc\/mdz413.041","article-title":"Results of a first panTRK IHC ringtrial","volume":"30","author":"De Winne","year":"2019","journal-title":"Ann. Oncol."},{"issue":"3","key":"10.1016\/j.lungcan.2020.05.019_bib0165","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1080\/14737140.2019.1562343","article-title":"ALK testing methods: is there a winner or loser?","volume":"19","author":"Kozuma","year":"2019","journal-title":"Expert Rev. Anticancer Ther."},{"issue":"5","key":"10.1016\/j.lungcan.2020.05.019_bib0170","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00428-016-2000-3","article-title":"Testing for ROS1 in non-small cell lung cancer: a review with recommendations","volume":"469","author":"Bubendorf","year":"2016","journal-title":"Virchows Arch."},{"issue":"28","key":"10.1016\/j.lungcan.2020.05.019_bib0175","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.1200\/JCO.2015.65.8732","article-title":"Differential crizotinib response duration among ALK fusion variants in ALK-Positive non-small-Cell lung Cancer","volume":"34","author":"Yoshida","year":"2016","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.lungcan.2020.05.019_bib0180","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s11523-019-00631-x","article-title":"Distribution of ALK fusion variants and correlation with clinical outcomes in chinese patients with non-small cell lung Cancer Treated with crizotinib","volume":"14","author":"Su","year":"2019","journal-title":"Target. Oncol."},{"issue":"8","key":"10.1016\/j.lungcan.2020.05.019_bib0185","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1136\/jclinpath-2012-201329","article-title":"Aberrant anaplastic lymphoma kinase expression in high-grade pulmonary neuroendocrine carcinoma","volume":"66","author":"Nakamura","year":"2013","journal-title":"J. Clin. Pathol."},{"issue":"1","key":"10.1016\/j.lungcan.2020.05.019_bib0190","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/his.13842","article-title":"Anaplastic lymphoma kinase expression in small-cell lung cancer","volume":"75","author":"Kondoh","year":"2019","journal-title":"Histopathology"},{"issue":"4","key":"10.1016\/j.lungcan.2020.05.019_bib0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0196556","article-title":"Performance of next-generation sequencing on small tumor specimens and\/or low tumor content samples using a commercially available platform","volume":"13","author":"Morris","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.lungcan.2020.05.019_bib0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/PO.19.00048","article-title":"STRN-ALK rearranged malignant peritoneal mesothelioma with dramatic response following ceritinib treatment","volume":"3","author":"R\u00fcschoff","year":"2019","journal-title":"JCO Precis. Oncol."},{"issue":"2","key":"10.1016\/j.lungcan.2020.05.019_bib0205","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1001\/jamaoncol.2017.2918","article-title":"Identification of ALK rearrangements in malignant peritoneal mesothelioma","volume":"4","author":"Hung","year":"2018","journal-title":"JAMA Oncol."}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500220304426?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500220304426?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T12:47:15Z","timestamp":1759236435000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500220304426"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":41,"alternative-id":["S0169500220304426"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2020.05.019","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NTRK and ALK rearrangements in malignant pleural mesothelioma, pulmonary neuroendocrine tumours and non-small cell lung cancer","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2020.05.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}